Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares JPMorgan USD Emerging Markets Bond ETF vs Sana Biotechnology Inc — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $95.02, while Sana Biotechnology Inc trades at $3.83 (market cap $1.13B). Which is the better fit depends on your goals.
| EMB | SANA | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $97.74 | $5.92 |
52-Week Low | $92.95 | $2.68 |
Market Cap | — | $1.13B |
Enterprise Value | — | $1.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
